GPT and Hyperbilirubinemia: Elevation of aspartate aminotransferase was the most common severe adverse event (11/52, 21.2%) in the HAIC group, followed by the elevation of alanine aminotransferase (7/52, 13.5%) and hyperbilirubinemia (7/52, 13.5%).